Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mosel has been very quiet, huh ?
where did you hear this ?
He is with it. Just like all of those, he needs a chance and acceptance of something new. Alpha, NJ seems like the best bet for the technology. Regarding cars, who knows, although the pictures of the Coates Kenworth hydrogen fueled semi, provided by Jack Mosel of H2 Technologies, sure looks like a step in the right direction.
Could be. Only time will tell.
Based on the recent newspaper article the Alpha project must be real. I have no idea why Mosel would have written that Coates would supply 8-10 generators and 2 semi's. if it wasn't part of that project. For that reason I believe it's for real and the long time between PR's makes me think that nothing will be released unless it's absolutely for real.
I know that's a stretch based on some previous PR's, but it's what I think. No matter what PR comes out there will be the typical doubters. Again, only time will tell. At the moment, it's hardly worth writing about.
A company doesn't have to be a corporation to exist. It can be a sole proprietorship (for example) and later incorporate. Make sense ?
Linked without a shred of stated truth ? Jack stated it. If you don't want to believe him that's your right, but there were Coates shareholders at the final Alpha meeting who met him and got info first hand. It might not be good enough for you but it is for me.
Only time will tell, not repetitive negative info that is written time and time again, which I thought wasn't allowed on this site.
If you would have bothered to read any of the info written or posted by Jack Mosel of H2 you would know that this H2 project alone includes 8-10 Coates generators as well as 2 Coates powered semi trucks.
You conveniently left out the retort to this, which says most of that post is BS.
You might want to re-read my post again. I wrote about trusting Mosel and you wrote about trusting what Coates has put out. Try to stay focused.
Certainly for most of us. There's an old saying, "Whiners whine and doers do". It appears to me that the H2-Coates partnership is out to do. How far it will go, nobody knows, but the combination of technologies seems to make a lot of sense.
MW hydrogen fueled generators and hydrogen fueled trucks.
That's why I pointed out that I didn't know when the funds were going to be distributed. They very well may not have the cash in their pockets yet since the approval to move ahead happened so recently. Funds for construction projects are typically given out in tranches along the course of the job. And I don't think the statement about the $50 million is unproven since it came directly from Mosel, unless you just don't trust him.
I don't know the timing of the funds being distributed but the Alpha project is a $50 million job and funding has been secured. Whatever Coates's share of that is must be a nice hunk of change, don't you think ? The next hurdle will be getting through the permitting process.
And what's the big deal if the share split happens ? Monetarily everyone will still own the same amount. And if it ever happens the main reason will have to be that it will make the stock look more attractive to buyers.
Probably only weeks away until the Top Line data is released. That likely will tell the story of the results of the 2B. If it's positive as expected it should certainly pique the interest of the pharma companies who would like such a drug in their line up.
I sure hope that it shows it's been effective in 70+% of the 2B patients. That would be consistent with the results of the compassionate care users and would be a fantastic result.
There was a lot of good stuff presented. Can't wait for the top line data to be released which should paint a picture of what the 2B results will be.
The company still seems to be little known. I know many people who own it and nobody is selling a share at least until the 2B results are out and if a run up occurs, and probably not until a deal to sell is consummated.
I bought more this past week.
Government contracts don't have to take a long time to come to be if they determine they can only get the product they want from one vendor, since there is no competition.
I think it would have if they didn't give the CEO 500,000 options. That kind of dilution can just take the wind out of the sails.
The last 2B patient should be done. I hope they put out a PR soon with some data regarding that. More than once they have stated the percentage of MIS416 users who have asked to stay on it. They must have updated info on that.
Their data will also be presented at the big neurological get together in Boston next week. I hope they're smart enough to exploit the results of those presentations as well.
To this point though, they haven't been much of a marketing machine. Info that gets released is sporadic at best.
I own a boat load of shares. I can't find a down side but the 2b results are where the proof is. We'll probably hear some top line results in a couple of months. That should be a pretty good indicator of where it's going.
With so many MIS416 users wanting to stay on the drug and no safety issues found it sure looks good to this point.
I can only assume you keep watching hoping for a pink engine. would seem to be right up your alley.
The Secure Supplies presentation is on both their website and Facebook page. The process is described as revolutionary and the Coates megawatt engine as the world's first.
Medcac, use the ignore feature on this site. It makes the visit here more enjoyable.
You're right. The 2B trial ends toward end of April. Since earlier PR indicated the vast majority of patients were asking to stay on the drug after their trial, I assume a similar PR will come out once the 2B is done.
Abstracts from Innate studies will be presented next month at a Neurology conference in Boston. Very good exposure to the scientific/medical world. I wouldn't be a bit surprised if the CEO goes to meet with pharma people. At least I hope he goes. Seems like a good forum to rub elbows with prospective buyers.
My last sale was at 65 cents about 5 years ago.
Apparently so are you.
Robert Peach is on the Innate board and sold Receptos, a company I believe he co-founded, for $7.2 billion a couple of years ago. As I understand it, Receptos had a drug in 2B trial for the first phase of MS and for ulcerative colitis.
Celgene, the buyer, spoke at a conference recently suggesting they expect that drug to sell in the $4-6 billion area.
It has been published that the market for the Innate drug is $7 billion and there is no other drug for SPMS. If, for example, the drug got a 50% market share plus there is use for the drug in the cancer arena as also published (ovarian cancer was mentioned in an article I read) we could be looking at sales at a similar size to the Receptos/Celgene drug, don't you think ?
Take $7.2 billion into around 250,000,000 shares and you have a very happy pay day. Who knows what will happen but I'd welcome other opinions.
There was a new article about Innate released today by Bloomberg. It has more focus on the company than the past politically based stories.
I continue to be amazed that the authors don't cite some of the statistics about patients staying on the drug. That's really the meat of what Innate has accomplished to date in my mind.
Even though this looks like a company with a solid drug coming down the pipe, like so many penny stocks it moves quite a bit based on news. The Price and Collins news has become a little old so I think interest isn't what it was, aside from the day traders, who you can see in the Level II screens on your brokerage account. They will sell for a couple pennies more and buy for a few cents less, over and over again.
My guess is we need a new news story to keep things rolling. Otherwise i would expect a lull.
And it doesn't appear that a whole lot of people know about this message board so unless there's news to talk about it probably will remain fairly quiet.
What do you mean by "this guy" ?
Just go to their website and look at the past CEO presentations, as well as some of the interviews with the drug users and you will be impressed. I was especially touched by one women who said she had SPMS so bad she was considering euthanasia. But after taking the drug for some time she is back to driving her car, among other things.
And their plan is simple. Finalize the 2B trial in April, report on the results by September, and either partner with big pharma, or preferably sell the company to big pharma in the 4th quarter.
Other pertinent info is that they believe the market for the drug for SPMS is $7 billion+. There is no current drug on the market for that condition.
A number I researched that is an average multiple for the sale of small biotechs is 4, therefore if it was agreed that sales for the product annually would be $1 billion, the company would sell for $4 billion, as I understand it.
If the current options available are exercised there will be just under 250,000,000 shares outstanding at that point.
I can't tell you that what I've written here is positively, absolutely right, but it is what I've found with my research.
Glad to find this board. I started buying in late 2015.
I think I've read everything I can on this company. I just can't find a fatal flaw. People have been using the drug for as long as 7 years through the compassionate care program in New Zealand. That's pretty amazing.
I read that 90% of the 2B trial patients have asked to stay on the drug after their 1 year test. The CEO recently met with 20 pharma companies that are following the results and have an interest in buying Innate.
Am I missing something that doesn't make this look like a big winner ?
He confirmed that there is a deal with Coates and laid out how the technology would work together and who the target markets were. He also insinuated that in due time there would be marketing materials laying out the joint effort.
Seems like a nice guy with a lot of passion for what he's doing. He was nice enough to send along an E Christmas card.
I do. Having been in contact with Donatelli a few times now so it sounds like it's a go.
I guess the best way to answer you is to say that he elaborated on what was said in the other communications. It was a rather lengthy email for sure.
I don't think you would have found anything that was earth shattering as compared to the other info that has been printed and some of the info seemed "canned", as to say that it might be what you'll see in future marketing info, but one thing is for sure. This guy is psyched about the Coates relationship and believes it can be a game changer in the markets they are after.
I responded earlier but I don't see it. I had deleted the email a couple of days after I got it, which I do routinely.
If you don't believe what I've written, email Donatelli yourself. I know he also responded to one other person so he seems eager to share the info about the deal.
No, I didn't think to ask about the financials. At the time I wrote to him I was just trying to get a confirmation that the deal was for real.
His reply both discussed some specifics regarding the contract and laid out what the product offerings would be, as well as who he sees as the target market for those products.
You could sense his excitement about the products in his writing. Of course the next big question is, can they sell it.
I emailed Mr. Donatelli, the CEO of Secure, and received a rather lengthy response back from him confirming the deal and laying out their plan. It's for real.
He was so responsive that I'd guess that if you wrote to him with questions you'd likely get a response too.
Maybe he's the new Oz.
He has considered it in the past so don't be surprised if it happens. Published statements such as the ones we're talking about certainly are defamatory enough to affect potential buyers decision to purchase the stock or not, as well as affecting the stock price.
Todays juries have been very generous in their awards for this type of claim. Imagine a 75 year old man in front of the jury claiming that his business, that he built from scratch, has been irreparably harmed by the constant unfounded claims published here and you've got yourself a guilty. How could the defendant show anything more in a court of law other than that loans have been taken out to support the business and as a result stock was issued to secure the loan.
No matter what you think, you can't prove otherwise, or go ahead and prove it to us. You have proven nothing so far. It's all been conjecture and that doesn't come close to cutting it in a court of law.
I went to one years ago. Worth the trip.
Cash deposits don't seem to matter. They don't seem to make it to the financials.
My personal belief is that if George wanted to kill the public company he would have done it by now. The products have been developed for many years under the COTE umbrella and what gets developed by a public company allows for the benefit of the shareholders, including the "owners".
George has so many shares that if there is even a minor uptick in the share price, he benefits greatly, as he should. To pull the rug out from under shareholders would prove to be devastating to the company. A class action suit would tie up everything and there's no benefit to him at all. And it would happen.
He apparently loves what he does, is looking for success and a positive legacy, and hopefully he has a happy ever after ending. For him to screw some shareholders seems senseless, don't you think ?